我们对融资月报进行了框架与内容升级：从过去聚焦创新药，新增医疗器械、数字健康及MNC并购追踪，覆盖更完整的全球医疗资本版图根据Pitchbook和我们专有的数据库分析，全球健康产业延续高景气，年内投融资达2,844亿美元，生物科技占比近70%；AI加速渗透可穿戴、慢病管理与智能诊疗等领域核心推荐标的：礼来制药（LLY US，增持），诺华制药（NVS US，增持），Veeva System（VEEV...
Source Link我们对融资月报进行了框架与内容升级：从过去聚焦创新药，新增医疗器械、数字健康及MNC并购追踪，覆盖更完整的全球医疗资本版图根据Pitchbook和我们专有的数据库分析，全球健康产业延续高景气，年内投融资达2,844亿美元，生物科技占比近70%；AI加速渗透可穿戴、慢病管理与智能诊疗等领域核心推荐标的：礼来制药（LLY US，增持），诺华制药（NVS US，增持），Veeva System（VEEV...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.